Non-Adherence to Statin Treatment in Older Patients with Peripheral Arterial Disease Depending on Persistence Status

dc.contributor.authorWawruch Martin
dc.contributor.authorWimmer Gejza
dc.contributor.authorMurin Jan
dc.contributor.authorPaduchova Martina
dc.contributor.authorPetrova Miriam
dc.contributor.authorTesar Tomas
dc.contributor.authorMatalova Petra
dc.contributor.authorHavelkova Beata
dc.contributor.authorTrnka Michal
dc.contributor.authorAarnio Emma
dc.contributor.organizationfi=biolääketieteen laitos|en=Institute of Biomedicine|
dc.contributor.organization-code2607100
dc.converis.publication-id51116309
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/51116309
dc.date.accessioned2022-10-28T14:32:11Z
dc.date.available2022-10-28T14:32:11Z
dc.description.abstractThe effectiveness of statins in secondary prevention of peripheral arterial disease (PAD) largely depends on patients' adherence to treatment. The aims of our study were: (a) to analyze non-adherence during the whole follow-up in persistent patients, and only during persistence for non-persistent patients; (b) to identify factors associated with non-adherence separately among persistent and non-persistent patients. A cohort of 8330 statin users aged >= 65 years, in whom PAD was newly diagnosed between January 2012-December 2012, included 5353 patients persistent with statin treatment, and 2977 subjects who became non-persistent during the 5-year follow-up. Non-adherence was defined using the proportion of days covered <80%. Patient- and statin-related characteristics associated with non-adherence were identified with binary logistic regression. A significantly higher proportion of non-adherent patients was found among non-persistent patients compared to persistent subjects (43.6% vs. 29.6%; p < 0.001). Associated with non-adherence in both persistent and non-persistent patients was high intensity statin treatment, while in non-persistent patients, it was employment and increasing number of medications. In patients with a poor adherence during their persistent period, an increased risk for discontinuation may be expected. However, there is also non-adherence among persistent patients. There are differences in factors associated with non-adherence depending on patients' persistence.
dc.identifier.eissn2227-9059
dc.identifier.jour-issn2227-9059
dc.identifier.olddbid188839
dc.identifier.oldhandle10024/171933
dc.identifier.urihttps://www.utupub.fi/handle/11111/56358
dc.identifier.urnURN:NBN:fi-fe2021042826980
dc.language.isoen
dc.okm.affiliatedauthorAarnio, Emma
dc.okm.discipline3111 Biomedicineen_GB
dc.okm.discipline3111 Biolääketieteetfi_FI
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherMDPI
dc.publisher.countrySwitzerlanden_GB
dc.publisher.countrySveitsifi_FI
dc.publisher.country-codeCH
dc.relation.articlenumberARTN 378
dc.relation.doi10.3390/biomedicines8100378
dc.relation.ispartofjournalBiomedicines
dc.relation.issue10
dc.relation.volume8
dc.source.identifierhttps://www.utupub.fi/handle/10024/171933
dc.titleNon-Adherence to Statin Treatment in Older Patients with Peripheral Arterial Disease Depending on Persistence Status
dc.year.issued2020

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
biomedicines-08-00378-v3.pdf
Size:
261.24 KB
Format:
Adobe Portable Document Format
Description:
Publishers's PDF